Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
International Clinical Trials Day is celebrated on May 20 to honour clinical research advancements. International Clinical Trials Day 2025 is celebrated globally on May 20th to recognize the very first controlled trial by James Lind in 1747 and to honour the contributions of researchers, patients, and sponsors in advancing medical science. This yea...
The success of drug development, commercialization & lifecycle management hinges on the ability to anticipate challenges, accelerate innovation, and adopt intelligent transformation strategies. Whether complying with regulatory changes, modernizing data systems, or optimizing clinical operations, life sciences companies need a strategic partner...
World Asthma Day is a timely reminder of the growing global burden of asthma and the urgent need for new solutions. Asthma is a major chronic respiratory disease affecting people of all ages. It is the most common chronic disease among children are essential to bring those innovations to patients quickly and safely. The Growing Burden of Asthma and...
When studies stall or derail, sponsors need a clinical trial rescue strategy that’s fast, cost- & time-efficient, and experienced with highly qualified data experts. As a leading Biometrics CRO, Navitas Life Sciences has designed flexible, scalable Functional Service Provider (FSP) models tailored to meet diverse sponsor needs and budget...
Built for Biotech. Start Smart. Scale Fast. Breakthrough science begins with bold ambition and realizing its potential takes the right partner. As an experienced Biotech CRO, Navitas Life Sciences recognizes the unique challenges that emerging biopharma and biotech innovators face: limited resources, accelerated timelines, and the critical need to ...
The pharmaceutical industry is experiencing a paradigm shift in medical writing, driven by artificial intelligence (AI), structured content authoring, and automation. Navitas Life Sciences’ 3rd Medical Writing Roundtable, hosted by Dr Latika Sharma and Dr. Sara Giadrossi, brought together industry leaders from 10+ global pharmaceutical compa...
The pharmaceutical industry is undergoing a significant transformation driven by digital innovation and artificial intelligence (AI). It has become increasingly beneficial to leverage AI powered tools and cloud based regulatory solutions to streamline regulatory submissions. These advancements enhance efficiency, improve data exchange, and ensure c...
The global generics market is on an accelerated growth path, with the U.S. leading the way, projected to surpass USD 508.37 billion by 2034 at a CAGR of 12.00%. This momentum is driven by rising healthcare costs, expiring patents, and increasing regulatory support for generic drug approvals. However, growth brings complexity. Regulatory scrutiny is...
Ensuring Compliance with the Windsor Framework The Windsor Framework is now implemented, transforming the regulatory landscape for pharmaceutical companies operating in the UK. While the framework simplifies processes by enabling a UK-wide licensing system under the Medicines and Healthcare products Regulatory Agency (MHRA), companies that have not...
Phase 1 clinical trials are the foundation of clinical drug development, marking the transition from laboratory research to human testing. These first-in-human trials are designed to evaluate the safety, dosage, and pharmacokinetics of investigational drugs in a small group of healthy volunteers or patients. The insights gained at this stage are cr...